![Anthony Man](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Anthony Man, MD, is an Independent Member-Supervisory Board at MediGene AG.
He is on the Board of Directors at MediGene AG.
Dr. Man was previously employed as a Global Head-Clinical Development by Novartis Pharma AG and a Chief Executive Officer by Basilea Pharmaceutica AG.
Postes actifs de Anthony Man
| Sociétés | Poste | Début |
|---|---|---|
| MEDIGENE AG | Directeur/Membre du Conseil | 16/12/2020 |
Anciens postes connus de Anthony Man
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01/08/2021 |
| BASILEA PHARMACEUTICA AG | President | 31/12/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
